David Hung, Nuvation Bio’s CEO, explains the company’s focus on providing patients with better drugs.
David Hung
Advertisement
David Hung is president, CEO, and founder of Nuvation Bio.
Articles by David Hung
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
DTP is Scaling Fast, the Safety Infrastructure is Not
2
U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels
3
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
4
FDA Pauses Release of New CRL’s Following Citizen’s Petition
5